REPL Replimune
- 6.420
- -0.030-0.47%
- 6.420
- 0.0000.00%
Replimune News
Analysts Are Bullish on Top Healthcare Stocks: Replimune Group (REPL), Merck & Company (MRK)
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC)
Barclays Maintains Overweight on Replimune Group, Lowers Price Target to $13
Replimune Group Analyst Ratings
JPMorgan Adjusts Replimune Price Target to $38 From $42, Maintains Overweight Rating
HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48
Replimune Group Analyst Ratings
Replimune Group Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Scholar Rock Holding (SRRK), Replimune Group (REPL) and Precision BioSciences (DTIL)
Analysts Conflicted on These Healthcare Names: Replimune Group (REPL), Capricor Therapeutics (CAPR) and Intellia Therapeutics (NTLA)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Replimune Group (REPL) and Verve Therapeutics (VERV)
HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $50
Replimune Group Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Replimune Group (REPL)
Analysts Offer Insights on Healthcare Companies: Enlivex (ENLV), Replimune Group (REPL) and Ultragenyx Pharmaceutical (RARE)
HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $51 Price Target
Replimune Group Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Replimune Group (REPL)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amneal Pharmaceuticals (AMRX), Replimune Group (REPL) and Gilead Sciences (GILD)
Analysts Are Bullish on Top Healthcare Stocks: Aldeyra Therapeutics (ALDX), Replimune Group (REPL)
Analysis
Price Target
No Data
